{"id":4936,"date":"2025-10-27T10:13:01","date_gmt":"2025-10-27T07:13:01","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=4936"},"modified":"2025-10-30T13:22:59","modified_gmt":"2025-10-30T10:22:59","slug":"avidity-biosciences-enters-into-agreement-to-be-acquired-by-novartis","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/fr\/avidity-biosciences-enters-into-agreement-to-be-acquired-by-novartis\/","title":{"rendered":"Avidity Biosciences va \u00eatre acquis par Novartis"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Avidity Biosciences, qui d\u00e9veloppe une th\u00e9rapie de saut d&#039;exon 44 pour la dystrophie musculaire de Duchenne, a annonc\u00e9 avoir conclu un accord de fusion d\u00e9finitif avec Novartis AG (\u201c Novartis \u201d) qui a \u00e9t\u00e9 approuv\u00e9 \u00e0 l&#039;unanimit\u00e9 par les conseils d&#039;administration des deux soci\u00e9t\u00e9s.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cette acquisition fera suite \u00e0 la scission des programmes de cardiologie de pr\u00e9cision en phase pr\u00e9coce d&#039;Avidity au sein de SpinCo, qui devrait \u00eatre cot\u00e9e en bourse. SpinCo sera dirig\u00e9e par Kathleen Gallagher, actuellement directrice des programmes d&#039;Avidity, au poste de directrice g\u00e9n\u00e9rale. Sarah Boyce, actuellement directrice g\u00e9n\u00e9rale d&#039;Avidity, pr\u00e9sidera le conseil d&#039;administration.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Novartis acquerra les programmes et le pipeline d&#039;Avidity en neurosciences et aura acc\u00e8s \u00e0 sa plateforme d&#039;administration diff\u00e9renci\u00e9e d&#039;ARN. L&#039;accord comprend trois programmes de d\u00e9veloppement clinique avanc\u00e9\u00a0: le delpacibart zotadirsen (del-zota) pour le traitement de la dystrophie musculaire de Duchenne (DMD), le delpacibart \u00e9tedesiran (del-desiran) pour le traitement de la dystrophie myotonique de type 1 (DM1) et le delpacibart braxlosiran (del-brax) pour le traitement de la dystrophie musculaire facio-scapulo-hum\u00e9rale (FSHD).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Apprendre encore plus<\/strong>: <a href=\"https:\/\/dmdwarrior.com\/fr\/del-zota-dmd-rna-therapy-from-avidity-biosciences-reverses-the-progression-of-disease\/\">La th\u00e9rapie par ARN Del-Zota DMD de Avidity Biosciences inverse la progression de la maladie<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Avidity Biosciences, which is developing an exon 44 skipping therapy for Duchenne muscular dystrophy, announced that it has entered into a definitive merger agreement with Novartis AG (&#8220;Novartis&#8221;) which has been unanimously approved by the Boards of Directors of both companies. The acquisition will follow the separation of Avidity&#8217;s early-stage precision cardiology programs into SpinCo, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4938,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[126,141,127,246,447],"class_list":["post-4936","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-avidity-biosciences","tag-exon-44","tag-exon-44-skipping","tag-exon-44-skipping-therapies","tag-novartis"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts\/4936","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/comments?post=4936"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/posts\/4936\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/media\/4938"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/media?parent=4936"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/categories?post=4936"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/fr\/wp-json\/wp\/v2\/tags?post=4936"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}